Welcome to our dedicated page for Delphx Cap Mkts news (Ticker: DPXCF), a resource for investors and traders seeking the latest updates and insights on Delphx Cap Mkts stock.
DelphX Capital Markets Inc. (OTCQB: DPXCF) generates news that reflects its focus on structured products at the intersection of fixed-income and cryptocurrency markets. The company’s disclosures highlight product development, capital-raising transactions, and initiatives related to its Quantem Crypto Securities (QCS) program.
Recent announcements have emphasized non-brokered private placements of units composed of common shares and warrants, with proceeds intended for working capital, corporate overhead, or general corporate purposes. These updates often include details on warrant terms, related party participation, and the need for TSX Venture Exchange approval, offering insight into how DelphX funds its activities and manages its capital structure.
Another key theme in DelphX news is the evolution of its QCS hedging solution. The company has reported marketing efforts to digital-asset treasuries and institutional participants, interest from a U.S. primary dealer evaluating a proof-of-concept deployment, and due diligence by multiple crypto-asset treasuries. It has also announced a non-binding letter of intent with Belgravia Hartford Capital Inc. for a potential first commercial QCS transaction aimed at protecting corporate Bitcoin treasury holdings.
Corporate governance and compensation developments also appear in DelphX news, including stock option grants under its option plan and transitions in the Chief Financial Officer role. For investors and observers, the DPXCF news stream offers ongoing context on product commercialization efforts, financing activities, and the company’s positioning within structured credit and digital-asset hedging.
Users following DelphX news can review these recurring topics to monitor how the company advances its proprietary CPO, CRN, and QCS offerings, and how regulatory approvals, market conditions, and institutional engagement influence its trajectory.
DelphX (OTCQB: DPXCF) announced that its board approved a grant of 1,450,000 stock options under its stock option plan on March 25, 2026. The Options have a two-year maturity and are exercisable at $0.08 per share.
700,000 Options were granted to insiders, including board members and executive officers, and all grants are in accordance with the Plan.
DelphX (OTCQB:DPXCF) provided a strategic update on its Bitcoin treasury initiative and institutional financing on March 24, 2026. The company is in final discussions for a senior secured lending facility with a major digital asset lender and plans a complementary USD $18M convertible debenture placement.
DelphX expects an initial capital deployment of ~USD $50M via a rules-based monthly tranche program and intends to embed its Quantem Collateralized Securities (QCS) platform to manage structured Bitcoin exposure.
DelphX (OTCQB: DPXCF; TSXV: DELX) closed a non‑brokered unit private placement on March 20, 2026, issuing 4,360,000 units at C$0.05 per unit for gross proceeds of C$218,000. Each unit includes one common share and one warrant exercisable at C$0.08 for two years. Securities are subject to a four‑month plus one‑day hold and completion is subject to TSX Venture Exchange approval. Net proceeds are intended for working capital and corporate overhead.
DelphX (OTCQB: DPXCF; TSXV: DELX) announced a non-brokered private placement of up to 2,500,000 units at C$0.05 per unit to raise up to C$125,000. Each unit includes one common share and one warrant exercisable at C$0.08 for two years.
Completion is subject to TSX Venture Exchange approval, securities will have a four-month-plus-one-day hold, insiders may participate, finder's fees may be paid, and net proceeds are for general corporate purposes.
DelphX Capital Markets (OTCQB: DPXCF) closed a non-brokered unit private placement issuing 4,100,000 units at C$0.05 per unit for gross proceeds of C$205,000 on Feb 25, 2026.
Each unit includes one common share and one warrant exercisable at $0.08 for two years; securities are subject to TSX Venture Exchange approval and a four-month plus one-day hold period. Net proceeds will be used for working capital and corporate overhead.
DelphX (OTCQB: DPXCF) intends a non-brokered private placement of up to 5,000,000 Units at C$0.05 per Unit to raise up to C$250,000 gross. Each Unit includes one common share and one warrant exercisable at C$0.08 for two years. Securities will be subject to a four-month plus one-day hold period and the Offering requires TSX Venture Exchange approval. DelphX may pay finder’s fees and insiders may participate, with net proceeds earmarked for general corporate purposes.
DelphX (OTCQB: DPXCF) intends to seek TSX Venture Exchange approval to extend the exercise period of 3,904,166 share purchase warrants exercisable at $0.20 by one year to January 30, 2027. All other warrant terms remain unchanged and the extension is subject to TSXV acceptance.
A total of 1,208,333 warrants are held by related parties, making the amendment a related party transaction under MI 61-101 and TSXV Policy 5.9, but exemptions for formal valuation and minority approval apply because the warrants' fair market value does not exceed 25% of DelphX market capitalization.
DelphX (OTCQB: DPXCF) closed a non-brokered unit private placement on January 30, 2026, issuing 3,000,000 Units at C$0.05 per Unit for gross proceeds of C$150,000. Each Unit includes one common share and one warrant exercisable at $0.08 for two years.
An insider subscribed for all 3,000,000 Units, making the transaction a related party participation under MI 61-101; DelphX relied on exemptions to formal valuation and minority approval. Closing remains subject to TSX Venture Exchange approval and issued securities carry a four-month-plus-one-day hold. Net proceeds are intended for working capital and corporate overhead.
DelphX (OTCQB: DPXCF, TSXV: DELX) announced a non-brokered private placement of up to 3,000,000 units at C$0.05 per unit for gross proceeds of C$150,000. Each Unit comprises one common share and one warrant exercisable at $0.08 for two years. Completion is subject to TSX Venture Exchange approval and securities will carry a 4-month plus one day hold period. Insiders may participate subject to insider trading policy. Net proceeds are intended for working capital and corporate overhead.
DelphX Capital Markets (OTCQB: DPXCF) announced a non-binding letter of intent with Belgravia Hartford Capital to pursue the first anticipated commercial transaction using DelphX's Quantem Crypto Security (QCS), specifically a QCS-collateralized put option intended to protect corporate Bitcoin treasury holdings. The LOI is non-binding and conditioned on definitive documentation, regulatory approvals, market conditions, and customary closing conditions.
DelphX also announced a CFO transition: Simon Selkrig will return as CFO effective January 1, 2026. The board approved a grant of 2,875,000 stock options, exercisable at $0.08 with a two-year maturity.